| Citation: |
LIU Jiujiang, LIN Hua. Research progress of serum biomarkers in acute respiratory distress syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(23): 124-128. DOI: 10.7619/jcmp.20213576
|
Acute respiratory distress syndrome (ARDS),with high mortality,is a clinical syndrome characterized by intractable hypoxemia induced by internal and external causes.However,the diagnosis mainly depends on clinical diagnosis and lacks specific test,which is often ignored.The use of biomarkers can provide important insights into the pathophysiological mechanism of ARDS and contribute to diagnosis,risk stratification and identification of candidate treatment targets.This study summarized the research progress of biomarkers in the clinical application of ARDS in recent years,and discussed its future research direction and prospects,in order to provide theoretical support for precision medicine in ARDS management.
| [1] |
FORCE A D T,RANIERI V M,RUBENFELD G D, et al.Acute respiratory distress syndrome: the Berlin Definition[J].JAMA,2012,307(23): 2526-2533.
|
| [2] |
BELLANI G,LAFFEY J G,PHAM T, et al.Epidemiology,patterns of care,and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries[J].JAMA,2016,315(8): 788-800. doi: 10.1001/jama.2016.0291
|
| [3] |
REILLY J P,CALFEE C S,CHRISTIE J D.Acute respiratory distress syndrome phenotypes[J].Semin Respir Crit Care Med,2019,40(1): 19-30. doi: 10.1055/s-0039-1684049
|
| [4] |
VAN DER ZEE P,RIETDIJK W,SOMHORST P, et al.A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality[J].Crit Care,2020,24(1): 243. doi: 10.1186/s13054-020-02913-7
|
| [5] |
JABAUDON M,FUTIER E,ROSZYK L, et al.Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe Sepsis in critically ill patients[J].Crit Care Med,2011,39(3): 480-488. doi: 10.1097/CCM.0b013e318206b3ca
|
| [6] |
JONES T K,FENG R,KERCHBERGER V E, et al.Plasma sRAGE Acts as a genetically regulated causal intermediate in Sepsis-associated acute respiratory distress syndrome[J].Am J Respir Crit Care Med,2020,201(1): 47-56. doi: 10.1164/rccm.201810-2033OC
|
| [7] |
FREMONT R D,KOYAMA T,CALFEE C S, et al.Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis[J].J Trauma,2010,68(5): 1121-1127.
|
| [8] |
TERPSTRA M L,AMAN J,VAN NIEUW AMERONGEN G P, et al.Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis[J].Crit Care Med,2014,42(3): 691-700. doi: 10.1097/01.ccm.0000435669.60811.24
|
| [9] |
VAN DER HEIJDEN M,VAN NIEUW AMERONGEN G P,KOOLWIJK P, et al.Angiopoietin-2,permeability oedema,occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients[J].Thorax,2008,63(10): 903-909. doi: 10.1136/thx.2007.087387
|
| [10] |
AGRAWAL A,MATTHAY M A,KANGELARIS K N, et al.Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients[J].Am J Respir Crit Care Med,2013,187(7): 736-742. doi: 10.1164/rccm.201208-1460OC
|
| [11] |
PARK J,PABON M,CHOI A M K, et al.Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts[J].BMC Pulm Med,2017,17(1): 204. doi: 10.1186/s12890-017-0532-1
|
| [12] |
ZHU Z,LIANG L,ZHANG R, et al.Whole blood microRNA markers are associated with acute respiratory distress syndrome[J].Intensive Care Med Exp,2017,5(1): 38. doi: 10.1186/s40635-017-0155-0
|
| [13] |
EISNER M D,PARSONS P,MATTHAY M A, et al.Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury[J].Thorax,2003,58(11): 983-988. doi: 10.1136/thorax.58.11.983
|
| [14] |
WARE L B,EISNER M D,THOMPSON B T, et al.Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury[J].Am J Respir Crit Care Med,2004,170(7): 766-772. doi: 10.1164/rccm.200310-1434OC
|
| [15] |
PARSONS P E,MATTHAY M A,WARE L B, et al.Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury[J].Am J Physiol Lung Cell Mol Physiol,2005,288(3): L426-L431. doi: 10.1152/ajplung.00302.2004
|
| [16] |
CALFEE C S,EISNER M D,PARSONS P E, et al.Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury[J].Intensive Care Med,2009,35(2): 248-257. doi: 10.1007/s00134-008-1235-0
|
| [17] |
WARE L B,MATTHAY M A,PARSONS P E, et al.Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome[J].Crit Care Med,2007,35(8): 1821-1828.
|
| [18] |
CALFEE C S,WARE L B,EISNER M D, et al.Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury[J].Thorax,2008,63(12): 1083-1089. doi: 10.1136/thx.2008.095588
|
| [19] |
GARCÍA-LAORDEN M I,LORENTE J A,FLORES C, et al.Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise[J].Ann Transl Med,2017,5(14): 283. doi: 10.21037/atm.2017.06.49
|
| [20] |
TSENG J S,CHAN M C,HSU J Y, et al.Procalcitonin is a valuable prognostic marker in ARDS caused by community-acquired pneumonia[J].Respirology,2008,13(4): 505-509. doi: 10.1111/j.1440-1843.2008.01293.x
|
| [21] |
WANG Q Q,FENG Q,ZHANG Y M, et al.Decreased microRNA 103 and microRNA 107 predict increased risks of acute respiratory distress syndrome and 28-day mortality in Sepsis patients[J].Medicine,2020,99(25): e20729. doi: 10.1097/MD.0000000000020729
|
| [22] |
KERGET B,KERGET F,KOÇAK A O, et al.Is endogenous carboxyhaemoglobin level a useful biomarker of clinical course and prognosis in COVID-19 patients[J].Int J Clin Pract,2021,75(11): e14680.
|
| [23] |
PORTACCI A,DIAFERIA F,SANTOMASI C, et al.Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure[J].Respir Med,2021,187: 106556. doi: 10.1016/j.rmed.2021.106556
|
| [24] |
XU Z,WU G M,LI Q, et al.Predictive value of combined LIPS and ANG-2 level in critically ill patients with ARDS risk factors[J].Mediators Inflamm,2018,2018: 1739615.
|
| [25] |
ZHAO Z,WICKERSHAM N,KANGELARIS K N, et al.External validation of a biomarker and clinical prediction model for hospital mortality in acute respiratory distress syndrome[J].Intensive Care Med,2017,43(8): 1123-1131. doi: 10.1007/s00134-017-4854-5
|
| [26] |
CALFEE C S,JANZ D R,BERNARD G R, et al.Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies[J].Chest,2015,147(6): 1539-1548. doi: 10.1378/chest.14-2454
|
| [27] |
SPADARO S,FOGAGNOLO A,CAMPO G, et al.Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients[J].Crit Care Lond Engl,2021,25(1): 74. doi: 10.1186/s13054-021-03499-4
|
| [28] |
MROZEK S,JABAUDON M,JABER S, et al.Elevated plasma levels of sRAGE are associated with nonfocal CT-based lung imaging in patients with ARDS: a prospective multicenter study[J].Chest,2016,150(5): 998-1007. doi: 10.1016/j.chest.2016.03.016
|
| [29] |
MEYER N J,LI M,FENG R, et al.ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio[J].Am J Respir Crit Care Med,2011,183(10): 1344-1353. doi: 10.1164/rccm.201005-0701OC
|
| [30] |
BHANDARI V,CHOO-WING R,HARIJITH A, et al.Increased hyperoxia-induced lung injury in nitric oxide synthase 2 null mice is mediated via angiopoietin 2[J].Am J Respir Cell Mol Biol,2012,46(5): 668-676. doi: 10.1165/rcmb.2011-0074OC
|
| [31] |
REILLY J P,WANG F,JONES T K, et al.Plasma angiopoietin-2 as a potential causal marker in Sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis[J].Intensive Care Med,2018,44(11): 1849-1858. doi: 10.1007/s00134-018-5328-0
|
| [32] |
DETERMANN R M,ROYAKKERS A A,HAITSMA J J, et al.Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients[J].BMC Pulm Med,2010,10: 6. doi: 10.1186/1471-2466-10-6
|
| [33] |
CALFEE C S,DELUCCHI K,PARSONS P E, et al.Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials[J].Lancet Respir Med,2014,2(8): 611-620. doi: 10.1016/S2213-2600(14)70097-9
|
| [34] |
FAMOUS K R,DELUCCHI K,WARE L B, et al.Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy[J].Am J Respir Crit Care Med,2017,195(3): 331-338. doi: 10.1164/rccm.201603-0645OC
|
| [35] |
National heart,lung,and blood institute acute respiratory distress syndrome (ARDS) clinical trials network.Comparison of two fluid-management strategies in acute lung injury[J].N Engl J Med,2006,354(24): 2564-2575.
|
| [36] |
MCAULEY D F,LAFFEY J G,O'KANE C M, et al.Simvastatin in the acute respiratory distress syndrome[J].N Engl J Med,2014,371(18): 1695-1703. doi: 10.1056/NEJMoa1403285
|
| [37] |
JABAUDON M,BLONDONNET R,ROSZYK L, et al.Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome[J].Am J Respir Crit Care Med,2015,192(2): 191-199. doi: 10.1164/rccm.201501-0020OC
|
| [38] |
JABAUDON M,BLONDONNET R,PEREIRA B, et al.Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data[J].Intensive Care Med,2018,44(9): 1388-1399. doi: 10.1007/s00134-018-5327-1
|
| [39] |
AUDARD J,GODET T,BLONDONNET R, et al.Inhibition of the receptor for advanced glycation end-products in acute respiratory distress syndrome: a randomised laboratory trial in piglets[J].Sci Rep,2019,9(1): 9227. doi: 10.1038/s41598-019-45798-5
|
| [40] |
METWALY S M,WINSTON B W.Systems biology ARDS research with a focus on metabolomics[J].Metabolites,2020,10(5): 207. doi: 10.3390/metabo10050207
|
| [41] |
METWALY S,COTE A,DONNELLY S J, et al.Evolution of ARDS biomarkers: Will metabolomics be the answer[J].Am J Physiol Lung Cell Mol Physiol,2018,315(4): L526-L534. doi: 10.1152/ajplung.00074.2018
|
| [42] |
BOS L D,WEDA H,WANG Y, et al.Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome[J].Eur Respir J,2014,44(1): 188-197. doi: 10.1183/09031936.00005614
|
| [43] |
MCNEIL J B,SHAVER C M,KERCHBERGER V E, et al.Novel method for noninvasive sampling of the distal airspace in acute respiratory distress syndrome[J].Am J Respir Crit Care Med,2018,197(8): 1027-1035. doi: 10.1164/rccm.201707-1474OC
|
| [44] |
STRINGER K A,SERKOVA N J,KARNOVSKY A, et al.Metabolic consequences of Sepsis-induced acute lung injury revealed by plasma1H-nuclear magnetic resonance quantitative metabolomics and computational analysis[J].Am J Physiol Lung Cell Mol Physiol,2011,300(1): L4-L11. doi: 10.1152/ajplung.00231.2010
|
| [45] |
VISWAN A,SINGH C,RAI R K, et al.Metabolomics based predictive biomarker model of ARDS: a systemic measure of clinical hypoxemia[J].PLoS One,2017,12(11): e0187545. doi: 10.1371/journal.pone.0187545
|
| 1. |
杨可非，刘文靖，周新尧，姜泉. 基于“体脏合痹”理论探讨干燥综合征病机论治. 中国中医基础医学杂志. 2025(02): 236-240 .
| |
| 2. |
邹怡萌，邹纯朴，陈晓，朱杨壮壮，苏琳，胥孜杭. 基于“肺主皮毛”理论的中西联系与思考. 北京中医药大学学报. 2024(01): 42-48 .
| |
| 3. |
张盈，杨波，蔡新利，王霜，王迎春. 干燥综合征患者血清HMGB1、Progranulin与NK细胞亚群和间质性肺疾病的关系研究. 现代生物医学进展. 2024(20): 3867-3869 .
| |
| 4. |
陈嘉琪，杨建英，吴子华，张丽宁，张燕，胡琪，贺倩，黄子玮，余新波，罗静，陶庆文. 原发性干燥综合征合并间质性肺病的中医证候特点及相关因素分析. 中国实验方剂学杂志. 2023(08): 66-72 .
| |
| 5. |
彭艳茹，闫世艳，罗成，张宁，李睿，王玉光. 中医药联合西医治疗干燥综合征相关间质性肺疾病的临床疗效和安全性的系统评价. 中国医院用药评价与分析. 2023(08): 980-984 .
| |
| 6. |
王菲，时美红. 原发性干燥综合征患者唇腺组织中BTB/POZ结构域蛋白7及基质金属蛋白酶-9的表达与自身抗体的关系. 实用临床医药杂志. 2022(21): 98-102 .
本站查看
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: